上海
分享至
财联社1月15日电，莎普爱思公告，公司单剂量滴眼剂车间P2线及单剂量滴眼剂车间P3线通过药品GMP符合性检查。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
